For: | Crosignani A, Battezzati PM, Invernizzi P, Selmi C, Prina E, Podda M. Clinical features and management of primary biliary cirrhosis. World J Gastroenterol 2008; 14(21): 3313-3327 [PMID: 18528929 DOI: 10.3748/wjg.14.3313] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i21/3313.htm |
Number | Citing Articles |
1 |
T.M. Antonini, D. Samuel. Indications et résultats de la greffe hépatique (hors carcinome hépatocellulaire et hépatite fulminante). Gastroentérologie Clinique et Biologique 2009; 33(1): 44 doi: 10.1016/j.gcb.2008.11.004
|
2 |
Dario Degiorgio, Andrea Crosignani, Carla Colombo, Domenico Bordo, Massimo Zuin, Emanuela Vassallo, Marie-Louise Syrén, Domenico A. Coviello, Pier Maria Battezzati. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression. Journal of Gastroenterology 2016; 51(3): 271 doi: 10.1007/s00535-015-1110-z
|
3 |
Yazmín Karel Melchor-Mendoza, Braulio Martínez-Benítez, Aline Mina-Hawat, Gustavo Rodríguez-Leal, Ximena Duque, Segundo Moran-Villota. Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation Availability. Annals of Hepatology 2017; 16(3): 430 doi: 10.5604/01.3001.0009.8598
|
4 |
Frederik Nevens. PBC-transplantation and disease recurrence. Best Practice & Research Clinical Gastroenterology 2018; : 107 doi: 10.1016/j.bpg.2018.09.001
|
5 |
S. Lüth, C. Weiler-Normann, C. Schramm, A.W. Lohse. Autoimmunerkrankungen der Leber. Der Internist 2009; 50(3): 310 doi: 10.1007/s00108-008-2254-1
|
6 |
Jelena Kovač. Imaging of the Liver and Intra-hepatic Biliary Tract. Medical Radiology 2021; : 337 doi: 10.1007/978-3-030-38983-3_18
|
7 |
Hui Liu, Hong-Wei Xu, Yu-Zhen Zhang, Ya Huang, Guo-Qing Han, Tie-Jun Liang, Li-Li Wei, Cheng-Yong Qin, Cheng-Kun Qin. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World Journal of Gastroenterology 2015; 21(36): 10367-10374 doi: 10.3748/wjg.v21.i36.10367
|
8 |
Sehmus Olmez, Suleyman Sayar, Ufuk Avcioglu, İlyas Tenlik, Ersan Ozaslan, Hasan T. Koseoglu, Emin Altiparmak. The relationship between liver histology and noninvasive markers in primary biliary cirrhosis. European Journal of Gastroenterology & Hepatology 2016; 28(7): 773 doi: 10.1097/MEG.0000000000000637
|
9 |
Marlen Ivón Castellanos Fernández, Deyanira la Rosa Hernández, Diego Enrique Cabrera Eugenio, Wilson Palanca, Zaily Dorta Guridi, Licet González Fabián. Diagnosis and Treatment of Autoimmune Liver Diseases in a Tertiary Referral Center in Cuba. Current Therapeutic Research 2017; 85: 8 doi: 10.1016/j.curtheres.2017.04.002
|
10 |
Aksana Höblinger, Sven Jonas, Gereon Gäbelein, Tillmann Sauerbruch. Viszeralmedizin. 2015; : 351 doi: 10.1007/978-3-642-14301-4_24
|
11 |
Dan Han, Jiayi Liu, Erhu Jin, Wen He. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Japanese Journal of Radiology 2019; 37(5): 412 doi: 10.1007/s11604-019-00822-6
|
12 |
Luciano Adorini, Mark Pruzanski, David Shapiro. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. Drug Discovery Today 2012; 17(17-18): 988 doi: 10.1016/j.drudis.2012.05.012
|
13 |
William Otero R. El hígado en reumatología. Revista Colombiana de Reumatología 2015; 22(1): 1 doi: 10.1016/j.rcreu.2015.03.002
|
14 |
Danielle Cristiane Baldo, Alessandra Dellavance, Maria Lucia Gomes Ferraz, Luis Eduardo C. Andrade. Evolving liver inflammation in biochemically normal individuals with anti-mitochondria antibodies. Autoimmunity Highlights 2019; 10(1) doi: 10.1186/s13317-019-0120-x
|
15 |
Pietro Invernizzi. Geoepidemiology of autoimmune liver diseases. Journal of Autoimmunity 2010; 34(3): J300 doi: 10.1016/j.jaut.2009.12.002
|
16 |
Nurmeen Adil, Amna Jabbar Siddiqui, Syed Ghulam Musharraf. Metabolomics‐based researches in autoimmune liver disease: A mini‐review. Scandinavian Journal of Immunology 2022; 96(4) doi: 10.1111/sji.13208
|
17 |
Liam Zakko. Atlas of Dermatological Manifestations of Gastrointestinal Disease. 2013; : 171 doi: 10.1007/978-1-4614-6191-3_65
|
18 |
Pietro Invernizzi, Patrick S. C. Leung, Xiong Ma, M. Eric Gershwin. Liver Immunology. 2014; : 253 doi: 10.1007/978-3-319-02096-9_18
|
19 |
Jing Hieng Ngu, Richard Blair Gearry, Andrew Jeffrey Wright, Catherine Ann Malcolm Stedman. Low incidence and prevalence of primary biliary cirrhosis in Canterbury, New Zealand: a population-based study. Hepatology International 2012; 6(4): 796 doi: 10.1007/s12072-011-9329-0
|
20 |
|
21 |
Ting Duan, Han-Yu Jiang, Wen-Wu Ling, Bin Song. Noninvasive imaging of hepatic dysfunction: A state-of-the-art review. World Journal of Gastroenterology 2022; 28(16): 1625-1640 doi: 10.3748/wjg.v28.i16.1625
|
22 |
Tatjana Stojakovic, Thierry Claudel, Csilla Putz-Bankuti, Günter Fauler, Hubert Scharnagl, Martin Wagner, Harald Sourij, Rudolf E. Stauber, Karl Winkler, Winfried März, Thomas C. Wascher, Michael Trauner. Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. Atherosclerosis 2010; 209(1): 178 doi: 10.1016/j.atherosclerosis.2009.08.052
|
23 |
A Dellavance, LE Coelho Andrade. Immunologic derangement preceding clinical autoimmunity. Lupus 2014; 23(12): 1305 doi: 10.1177/0961203314531346
|
24 |
Frank Czul, Adam Peyton, Cynthia Levy. Primary Biliary Cirrhosis. Clinics in Liver Disease 2013; 17(2): 229 doi: 10.1016/j.cld.2012.12.003
|
25 |
Heather Francis, Cynthia J. Meininger. A review of mast cells and liver disease: What have we learned?. Digestive and Liver Disease 2010; 42(8): 529 doi: 10.1016/j.dld.2010.02.016
|
26 |
Henrik Nilsson, Lennart Blomqvist, Lena Douglas, Anders Nordell, Eduard Jonas. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. HPB 2010; 12(8): 567 doi: 10.1111/j.1477-2574.2010.00223.x
|
27 |
|
28 |
Liam Zakko, Justin Finch, Marti J. Rothe, Jane M. Grant-Kels. Atlas of Dermatological Manifestations of Gastrointestinal Disease. 2013; : 173 doi: 10.1007/978-1-4614-6191-3_66
|
29 |
Rachel M. Williamson, Jackie F. Price, Stephen Glancy, Elisa Perry, Lisa D. Nee, Peter C. Hayes, Brian M. Frier, Liesbeth A.F. Van Look, Geoffrey I. Johnston, Rebecca M. Reynolds, Mark W.J. Strachan. Prevalence of and Risk Factors for Hepatic Steatosis and Nonalcoholic Fatty Liver Disease in People With Type 2 Diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011; 34(5): 1139 doi: 10.2337/dc10-2229
|
30 |
Ranjana W. Minz, Navchetan Kaur, Shashi Anand, Ritu Aggarwal, Biman Saikia, Ashim Das, Yogesh K. Chawla. Complete spectrum of AMA-M2 positive liver disease in north India. Hepatology International 2012; 6(4): 790 doi: 10.1007/s12072-011-9326-3
|
31 |
Gary C. Kanel, Jacob Korula. Atlas of Liver Pathology. 2011; : 52 doi: 10.1016/B978-1-4377-0765-6.10003-5
|
32 |
Andreas E Kremer, Christian Rust, Peter Eichhorn, Ulrich Beuers, Stefan Holdenrieder. Immune-mediated liver diseases: programmed cell death ligands and circulating apoptotic markers. Expert Review of Molecular Diagnostics 2009; 9(2): 139 doi: 10.1586/14737159.9.2.139
|
33 |
Jocelyn Trottier, Andrzej Białek, Patrick Caron, Robert J. Straka, Jenny Heathcote, Piotr Milkiewicz, Olivier Barbier. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study. Digestive and Liver Disease 2012; 44(4): 303 doi: 10.1016/j.dld.2011.10.025
|
34 |
Deepak Garg, Arpit Nagar, Shaile Philips, Naoki Takahashi, Srinivasa R. Prasad, Alampady K. Shanbhogue, Dushyant V. Sahani. Immunological diseases of the pancreatico-hepatobiliary system: update on etiopathogenesis and cross-sectional imaging findings. Abdominal Imaging 2012; 37(2): 261 doi: 10.1007/s00261-011-9759-0
|